Patent Assignment
Reel/Frame 055524/0457
Assignment of Assignor's Interest
Recorded: 2021-03-08
Pages: 6
Assignors
BIOGEN IDEC MA INC.
Executed: 2009-07-17
SUNESIS PHARMACEUTICALS, INC.
Executed: 2009-07-17
Assignees
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
SUNESIS PHARMACEUTICALS, INC.
341 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Compounds Useful as Raf Kinase Inhibitors
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0863 →
Assignment of Assignor's Interest
Mar 8, 2021
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0173 →
Assignment of Assignor's Interest
Mar 8, 2021
From: CHEN, WEIRONG; FRANKLIN, LLOYD; GUAN, BING; JONES, JOHN HOWARD
To: BIOGEN IDEC MA INC.
Reel/Frame 055524/0371 →
Assignment of Assignor's Interest
Mar 8, 2021
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 055524/0525 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →